The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
The pharmaceuticals/drug therapy segment of conventional and alternative pain treatment market is expected to grow from $61.5 billion in 2024 and is projected to reach $96.3 billion by the end of 2029, at a CAGR of 9.4% during the forecast period of 2024 to 2029.
The devices segment of conventional and alternative pain treatment market is expected to grow from $34.7 billion in 2024 and is projected to reach $47.9 billion by the end of 2029, at a CAGR of 6.7% during the forecast period of 2024 to 2029.
Report Scope
This report covers the conventional and alternative pain treatments used by patients with chronic or acute pain. It provides the current and future market potential of conventional and alternative pain treatments and includes a detailed analysis of the competitive environment. The report covers the drivers, restraints and opportunities in the market; surveys the prevalence of or incidence of chronic diseases; and highlights emerging technologies for alternative treatment procedures. It includes market projections for 2029 and provides the market shares of key players.
In this analysis, the conventional and alternative pain treatment market is segmented based on pain management type into pharmaceuticals/drug therapy and devices. The pharmaceuticals/drug therapy segment is further segmented into non-narcotic analgesics, medical cannabis, narcotic analgesics, antimigraine agents, central nervous system (CNS) treatments, anesthetics, and other classes of pharmaceutical drug therapy. The devices segment of the conventional and alternative pain treatment market is further segmented into spine stimulators, electrotherapy/muscle stimulation, and other devices. Based on application, the overall conventional and alternative pain treatment market is segmented into orthopedic and musculoskeletal pain, general and broad pain management, surgical pain management, migraine/headache pain, neuropathic pain, cancer pain, fibromyalgia pain, and other pain types.
The overall conventional and alternative pain treatment market has also been segmented by geography into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa (MEA). Each regional analysis covers the region's leading countries, namely, the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries. Market data is provided for 2023, which serves as the base year; estimates are given for 2024 and forecast values for 2029.
Report Includes
- 48 data tables and 56 additional tables
- Analysis of the global market for conventional and alternative pain treatments
- Analyses of global market trends, with market revenue data from 2012-2023, estimates for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by pain management type, application and region
- Facts and figures pertaining to the market dynamics, technological advances, regulations, and the influence of macroeconomic factors
- A Porter's Five Forces analysis, a global supply chain analysis and a SWOT analysis
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- A look at recent patent grants
- Analysis of the industry structure and competitive landscape, including company market shares, strategic alliances, M&A activity and venture funding outlook
- Profiles of market leaders, including Medtronic, Abbott, GSK, Pfizer Inc., and Johnson & Johnson
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview of Types of Pain and Its Treatment
- Introduction
- The Perception of Pain
- How Pain is Treated
- Pain Management Techniques: Electrical Stimulation
- Pain Management Procedures
- Alternative Methods of Pain Management
- Growing Trend in Cannabis Treatment for Pain
- Treatment Using Alternatives for Chronic Pain
Chapter 3 Market Dynamics
- Introduction
- Market Drivers
- Rise in the Aging Population
- Increasing Integration of Artificial Intelligence in Medical Devices
- Rising Incidence of Chronic Diseases
- Growth of Public Health Programs That Address Chronic Pain
- Improvement in the Non-Drug Techniques
- Market Restraints
- Failure in Medical Device Designs
- Supply Chain Issues and Quality Concerns
- Market Opportunities
- Expanding Usage of Wearable Devices
- Technological Development for Conventional and Alternative Pain Treatment
- Future Trends and Possibilities
Chapter 4 Emerging Technologies and Developments
- Introduction
- Regenerative Medicine
- Advantages of Regenerative Pain Management
- Minuteman Procedure
- Peripheral Nerve Stimulation (PNS)
- VIA Disc Treatment
- Other Technologies
- Wearable Devices and Biofeedback
- Virtual Reality (VR) Therapy
- Artificial Intelligence (AI) in Pain Prediction
- Pain Management Clinical Trials
- Trends in Development of Conventional and Alternative Pain Treatment
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Market Breakdown by Pain Management Type
- Market Size and Forecast
- Pharmaceuticals/Drug Therapy
- Market Size and Forecast
- Non-Narcotic Analgesics
- Medical Cannabis
- Narcotic Analgesics
- Antimigraine Agents
- Central Nervous System (CNS) Treatments
- Anesthetics
- Other Classes
- Devices
- Market Size and Forecast
- Spine Stimulators
- Electrotherapy/Muscle Stimulation
- Other Devices
- Market Breakdown by Application
- Market Size and Forecast
- Orthopedic and Musculoskeletal Pain
- Market Size and Forecast
- General and Broad Pain Management
- Market Size and Forecast
- Surgical Pain Management
- Market Size and Forecast
- Migraine/Headache
- Market Size and Forecast
- Neuropathic Pain
- Market Size and Forecast
- Cancer Pain
- Market Size and Forecast
- Fibromyalgia Pain
- Market Size and Forecast
- Other Pain Types
- Market Size and Forecast
- Geographical Breakdown
- Market Analysis by Region
- Market Size and Forecast
- North America
- Market Size and Forecast
- U.S.
- Canada
- Mexico
- Europe
- Market Size and Forecast
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Market Size and Forecast
- China
- Japan
- India
- Australia and New Zealand
- Rest of Asia-Pacific
- Latin America
- Market Size and Forecast
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast
- South Africa
- GCC Countries
- Rest of the Middle East & Africa
Chapter 6 Competitive Intelligence
- Introduction
- Global Analysis of the Market and Its Leading Players
- Agreements, Collaborations and Partnerships
- 2023 Device Approvals
Chapter 7 Sustainability
- Importance of ESG in the Conventional and Alternative Pain Treatment Industry
- ESG Practices in the Pain Treatment Medical Device Industry
- Environmental Performance
- Social Performance
- Governance Performance
- ESG Ranking
- BCC Research Viewpoint
Chapter 8 Appendix
- Research Methodology
- References
- Company Profiles
- ABBOTT
- ABBVIE INC.
- AMGEN INC.
- BAXTER
- BAYER AG
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- BOSTON SCIENTIFIC CORP.
- GSK PLC
- JOHNSON & JOHNSON SERVICES INC.
- LILLY
- MEDTRONIC
- MERCK & CO. INC.
- NOVARTIS AG
- PFIZER INC.
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
